Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients

Abstract Multiple studies have reported a doubling in risk of Coronavirus Disease-2019 (COVID-19) among cancer patients. Here, we examine the potential biological rationale behind this recurrent epidemiological observation. By leveraging large-scale genome-wide transcriptional data of normal and mal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jennifer Yin Yee Kwan, Liang-Tzung Lin, Rachel Bell, Jeffrey P. Bruce, Christopher Richardson, Trevor J. Pugh, Fei-Fei Liu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5b5d721bd98047939c6e665fc34c1be2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5b5d721bd98047939c6e665fc34c1be2
record_format dspace
spelling oai:doaj.org-article:5b5d721bd98047939c6e665fc34c1be22021-12-02T13:19:22ZElevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients10.1038/s41598-021-83366-y2045-2322https://doaj.org/article/5b5d721bd98047939c6e665fc34c1be22021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83366-yhttps://doaj.org/toc/2045-2322Abstract Multiple studies have reported a doubling in risk of Coronavirus Disease-2019 (COVID-19) among cancer patients. Here, we examine the potential biological rationale behind this recurrent epidemiological observation. By leveraging large-scale genome-wide transcriptional data of normal and malignant tissues from adults and children, we found evidence of increased expression of SARS-CoV-2 viral entry genes in the cancer state, particularly in respiratory, gastrointestinal, and genitourinary tract tissues, with decreased expression in pediatric vs. adult samples. Additionally, by interrogating the temporal effects of radiotherapy on human peripheral blood mononuclear and mucosal cells, we observed important treatment-related alterations in host innate immunity, specifically type I interferon responses. Overall, cancers enhance expression of critical viral entry genes, and innate viral defenses can be dysregulated transiently during radiation treatments. These factors may contribute to the observed increased susceptibility to SARS-CoV-2 entry and severity of COVID-19 in cancer patients.Jennifer Yin Yee KwanLiang-Tzung LinRachel BellJeffrey P. BruceChristopher RichardsonTrevor J. PughFei-Fei LiuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jennifer Yin Yee Kwan
Liang-Tzung Lin
Rachel Bell
Jeffrey P. Bruce
Christopher Richardson
Trevor J. Pugh
Fei-Fei Liu
Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients
description Abstract Multiple studies have reported a doubling in risk of Coronavirus Disease-2019 (COVID-19) among cancer patients. Here, we examine the potential biological rationale behind this recurrent epidemiological observation. By leveraging large-scale genome-wide transcriptional data of normal and malignant tissues from adults and children, we found evidence of increased expression of SARS-CoV-2 viral entry genes in the cancer state, particularly in respiratory, gastrointestinal, and genitourinary tract tissues, with decreased expression in pediatric vs. adult samples. Additionally, by interrogating the temporal effects of radiotherapy on human peripheral blood mononuclear and mucosal cells, we observed important treatment-related alterations in host innate immunity, specifically type I interferon responses. Overall, cancers enhance expression of critical viral entry genes, and innate viral defenses can be dysregulated transiently during radiation treatments. These factors may contribute to the observed increased susceptibility to SARS-CoV-2 entry and severity of COVID-19 in cancer patients.
format article
author Jennifer Yin Yee Kwan
Liang-Tzung Lin
Rachel Bell
Jeffrey P. Bruce
Christopher Richardson
Trevor J. Pugh
Fei-Fei Liu
author_facet Jennifer Yin Yee Kwan
Liang-Tzung Lin
Rachel Bell
Jeffrey P. Bruce
Christopher Richardson
Trevor J. Pugh
Fei-Fei Liu
author_sort Jennifer Yin Yee Kwan
title Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients
title_short Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients
title_full Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients
title_fullStr Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients
title_full_unstemmed Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients
title_sort elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of covid-19 in cancer patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5b5d721bd98047939c6e665fc34c1be2
work_keys_str_mv AT jenniferyinyeekwan elevationinviralentrygenesandinnateimmunitycompromiseunderlyingincreasedinfectivityandseverityofcovid19incancerpatients
AT liangtzunglin elevationinviralentrygenesandinnateimmunitycompromiseunderlyingincreasedinfectivityandseverityofcovid19incancerpatients
AT rachelbell elevationinviralentrygenesandinnateimmunitycompromiseunderlyingincreasedinfectivityandseverityofcovid19incancerpatients
AT jeffreypbruce elevationinviralentrygenesandinnateimmunitycompromiseunderlyingincreasedinfectivityandseverityofcovid19incancerpatients
AT christopherrichardson elevationinviralentrygenesandinnateimmunitycompromiseunderlyingincreasedinfectivityandseverityofcovid19incancerpatients
AT trevorjpugh elevationinviralentrygenesandinnateimmunitycompromiseunderlyingincreasedinfectivityandseverityofcovid19incancerpatients
AT feifeiliu elevationinviralentrygenesandinnateimmunitycompromiseunderlyingincreasedinfectivityandseverityofcovid19incancerpatients
_version_ 1718393273349832704